4.6 Meeting Abstract

INTERIM ANALYSIS OF THE EF-14 TRIAL: A PROSPECTIVE, MULTI-CENTER TRIAL OF NOVOTTF-100A TOGETHER WITH TEMOZOLOMIDE COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GBM

Journal

NEURO-ONCOLOGY
Volume 16, Issue -, Pages -

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/neuonc/nou265.40

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available